Selventa is funded by industry-leading investors, including Flagship Ventures and Pappas Ventures. As a proud member of these families, Selventa has benefited from their guidance and insight.
Founded in 2000, Flagship Ventures focuses on creating, financing and building innovative companies. The firm’s strategy is to balance its investments across three principal business sectors: Therapeutics, Life Science Tools and Diagnostics, and BioEnergy/Cleantech. Flagship manages $600 million in early-stage funds and has an active portfolio of more than 40 companies.
Founded in 1994, Pappas Ventures only invests in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Each partnership or long-term collaboration brings promising technologies to commercial application – from concept to commerce. Pappas has helped more than 50 organizations turn breakthrough ideas into market-leading companies.